Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Association of objectively measured physical activity with established and novel cardiovascular biomarkers in elderly subjects: every step counts.

Klenk J, Denkinger M, Nikolaus T, Peter R, Rothenbacher D, Koenig W; ActiFE Study Group.

J Epidemiol Community Health. 2013 Feb;67(2):194-7. doi: 10.1136/jech-2012-201312. Epub 2012 Aug 27.

PMID:
22930799
2.

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.

N Engl J Med. 2008 May 15;358(20):2107-16. doi: 10.1056/NEJMoa0707064.

3.

Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.

Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, Koerbin G, Southcott E, Potter JM.

Intern Med J. 2009 Dec;39(12):812-8. doi: 10.1111/j.1445-5994.2009.01846.x.

PMID:
20233242
4.

High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.

Scheven L, de Jong PE, Hillege HL, Lambers Heerspink HJ, van Pelt LJ, Kootstra JE, Bakker SJ, Gansevoort RT; PREVEND study group.

Eur Heart J. 2012 Sep;33(18):2272-81. Epub 2012 Jun 27.

PMID:
22740385
5.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

PMID:
19539088
7.

Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.

Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH.

Am J Cardiol. 2009 May 15;103(10):1411-6. doi: 10.1016/j.amjcard.2009.01.355. Epub 2009 Apr 1.

PMID:
19427438
8.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.

Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT Study Group.

Clin Chem. 2012 Jan;58(1):200-8. doi: 10.1373/clinchem.2011.174292. Epub 2011 Dec 7.

9.

A link between impaired lung function and increased cardiac stress.

Wieshammer S, Dreyhaupt J, Basler B.

Respiration. 2010;79(5):355-62. doi: 10.1159/000265751. Epub 2009 Dec 10.

10.

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.

Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L.

Circulation. 2012 Apr 3;125(13):1605-16. doi: 10.1161/CIRCULATIONAHA.111.038729. Epub 2012 Feb 28.

11.

Multiple biomarker panels for cardiovascular risk assessment.

de Lemos JA, Lloyd-Jones DM.

N Engl J Med. 2008 May 15;358(20):2172-4. doi: 10.1056/NEJMe0801721. No abstract available.

PMID:
18480211
12.
13.

Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

J Hypertens. 2008 Jan;26(1):26-34.

PMID:
18090537
14.

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.

Akerblom Å, Wallentin L, Siegbahn A, Becker RC, Budaj A, Buck K, Giannitsis E, Horrow J, Husted S, Katus HA, Steg PG, Storey RF, Åsenblad N, James SK.

Clin Chem. 2012 Jan;58(1):190-9. doi: 10.1373/clinchem.2011.171520. Epub 2011 Nov 29.

15.

The impact of dialysis type on biomarkers for cardiovascular diseases.

Sahinarslan A, Güz G, Mutluay R, Okyay K, Demirtaş C, Paşaoğlu H, Yalçın R.

Turk Kardiyol Dern Ars. 2011 Sep;39(6):456-62. doi: 10.5543/tkda.2011.01289.

16.

Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?

Olsen MH, Sehestedt T, Lyngbaek S, Hansen TW, Rasmussen S, Wachtell K, Torp-Pedersen C, Hildebrandt PR, Ibsen H.

Curr Vasc Pharmacol. 2010 Jan;8(1):134-9.

PMID:
19485906
17.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.

Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2997-3003. doi: 10.1161/ATVBAHA.111.223669. Epub 2011 Sep 15.

18.

Elevated pro-brain natriuretic peptide, troponin T and malnutrition inflammatory score in chronic hemodialysis patients with overt cardiovascular disease.

Trimarchi H, Muryan A, Campolo-Girard V, Dicugno M, Barucca N, Lombi F, Young P, Pomeranz V, Forrester M, Alonso M, Iriarte R, Díaz ML, Lindholm B.

Nephron Clin Pract. 2011;117(3):c198-205. doi: 10.1159/000320195. Epub 2010 Aug 30.

PMID:
20805692
19.

Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers.

Codognotto M, Piccoli A, Zaninotto M, Mion MM, Ruzza L, Barchita A, Naso A, Plebani M.

J Nephrol. 2010 Jul-Aug;23(4):465-71.

PMID:
20540041
20.

Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.

Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.

Hemodial Int. 2010 Jul;14(3):308-15. doi: 10.1111/j.1542-4758.2010.00455.x. Epub 2010 Jun 28.

PMID:
20597992

Supplemental Content

Support Center